Plexiform neurofibromatosis: A case report
Tanzania Journal of Health Research · 10.07.2023 · 24 (3) · 286-291
DOI: 10.4314/thrb.v24i3.11 ↗Kurz gefasst
Fallbericht in der Zeitschrift Tanzania Journal of Health Research, online erschienen am 10.07.2023. Verfasst von Oscar Lucas Kivike.
Abstract (Originalsprache)
Neurofibroma is a tumor of connective tissue of a nerve which can develop within a major or minor nerve anywhere in the body. Neurofibromatosis is a group of genetic disorders that affects the cell growth of neural tissues. Plexiform neurofibromatosis is a type which affects a nerve plexus. Is diffuse, locally invasive, deep and may be associated with bony erosion and pain. It is actually a neurofibromatosis type I. It takes up to 30% of neurofibromatosis type I and mostly affects the maxillofacial region. 75% of patients who undergo surgical removal of the tumor are cured. The recurrence rate is 20%. Diagnosis is clinical, histopathology and genetic testing. Imaging investigations are X-rays, CT scans or MRIs. The treatment of choice for plexiform neurofibroma is surgery. Cutaneous neurofibromas can be treated by laser therapy. Chemotherapy is used to treat malignant neurofibromas. We report a case of a 21 years old male patient who presented with left-sided facial swelling involving the eyelid, cheek and left ear. The swelling was painless and made the face deform with a protruding mass hanging. Imaging investigations show tumour infiltration to involve the inner structures and facial bony erosion. Surgical intervention was performed to remove the tumor.
Zitieren
APA
Kivike, O. L. (2023). Plexiform neurofibromatosis: A case report. Tanzania Journal of Health Research, 24(3), 286-291. https://doi.org/10.4314/thrb.v24i3.11
Vancouver
Kivike OL. Plexiform neurofibromatosis: A case report. Tanzania Journal of Health Research. 2023;24(3):286-291. doi:10.4314/thrb.v24i3.11
BibTeX
@article{Kivike2023,
author = {Kivike, Oscar Lucas},
title = {Plexiform neurofibromatosis: A case report},
journal = {Tanzania Journal of Health Research},
year = {2023},
volume = {24},
number = {3},
pages = {286--291},
doi = {10.4314/thrb.v24i3.11}
}
EUVIMED